Avidity Biosciences, Inc.
EGFR nucleic acids and uses thereof

Last updated:

Abstract:

Disclosed herein are molecules and pharmaceutical compositions that mediate RNA interference against EGFR. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that mediate RNA interference against EGFR.

Status:
Grant
Type:

Utility

Filling date:

31 Mar 2017

Issue date:

29 Dec 2020